SE509618C2 - Farmaceutisk komposition för behandling av s k restless legs - Google Patents

Farmaceutisk komposition för behandling av s k restless legs

Info

Publication number
SE509618C2
SE509618C2 SE9700803A SE9700803A SE509618C2 SE 509618 C2 SE509618 C2 SE 509618C2 SE 9700803 A SE9700803 A SE 9700803A SE 9700803 A SE9700803 A SE 9700803A SE 509618 C2 SE509618 C2 SE 509618C2
Authority
SE
Sweden
Prior art keywords
quinine
pharmaceutical composition
general formula
treatment
loratadine
Prior art date
Application number
SE9700803A
Other languages
English (en)
Swedish (sv)
Other versions
SE9700803D0 (sv
SE9700803L (sv
Inventor
Goeran Blomqvist
Original Assignee
Goeran Blomqvist
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goeran Blomqvist filed Critical Goeran Blomqvist
Priority to SE9700803A priority Critical patent/SE509618C2/sv
Publication of SE9700803D0 publication Critical patent/SE9700803D0/xx
Priority to PCT/SE1998/000199 priority patent/WO1998039005A1/en
Priority to EP98902380A priority patent/EP1003517B1/de
Priority to DE69806248T priority patent/DE69806248T2/de
Priority to US09/380,295 priority patent/US6214837B1/en
Priority to AU58933/98A priority patent/AU5893398A/en
Priority to AT98902380T priority patent/ATE219675T1/de
Publication of SE9700803L publication Critical patent/SE9700803L/xx
Publication of SE509618C2 publication Critical patent/SE509618C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE9700803A 1997-03-06 1997-03-06 Farmaceutisk komposition för behandling av s k restless legs SE509618C2 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9700803A SE509618C2 (sv) 1997-03-06 1997-03-06 Farmaceutisk komposition för behandling av s k restless legs
PCT/SE1998/000199 WO1998039005A1 (en) 1997-03-06 1998-02-03 Pharmaceutical composition for the treatment of so-called restless legs
EP98902380A EP1003517B1 (de) 1997-03-06 1998-02-03 Pharmazeutische zubereitung zur behandlung sogenannter rastloser beine
DE69806248T DE69806248T2 (de) 1997-03-06 1998-02-03 Pharmazeutische zubereitung zur behandlung sogenannter rastloser beine
US09/380,295 US6214837B1 (en) 1997-03-06 1998-02-03 Pharmaceutical composition for the treatment of so-called restless legs
AU58933/98A AU5893398A (en) 1997-03-06 1998-02-03 Pharmaceutical composition for the treatment of so-called restless legs
AT98902380T ATE219675T1 (de) 1997-03-06 1998-02-03 Pharmazeutische zubereitung zur behandlung sogenannter rastloser beine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700803A SE509618C2 (sv) 1997-03-06 1997-03-06 Farmaceutisk komposition för behandling av s k restless legs

Publications (3)

Publication Number Publication Date
SE9700803D0 SE9700803D0 (sv) 1997-03-06
SE9700803L SE9700803L (sv) 1998-09-07
SE509618C2 true SE509618C2 (sv) 1999-02-15

Family

ID=20406044

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700803A SE509618C2 (sv) 1997-03-06 1997-03-06 Farmaceutisk komposition för behandling av s k restless legs

Country Status (7)

Country Link
US (1) US6214837B1 (de)
EP (1) EP1003517B1 (de)
AT (1) ATE219675T1 (de)
AU (1) AU5893398A (de)
DE (1) DE69806248T2 (de)
SE (1) SE509618C2 (de)
WO (1) WO1998039005A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003262860A1 (en) 2002-08-30 2004-03-19 Kyowa Hakko Kogyo Co., Ltd. Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders
SG146643A1 (en) 2003-09-17 2008-10-30 Xenoport Inc Treating or preventing restless legs syndrome using prodrugs of gaba analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3014911A (en) 1958-09-29 1961-12-26 Merck & Co Inc Derivatives of dibenzo[a, e]cycloheptatriene
US4282233B1 (en) 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US5759198A (en) * 1995-12-05 1998-06-02 Karell; Manuel L. Method and apparatus for treating and preventing leg cramps and other muscle contractions and sleep disorders
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions

Also Published As

Publication number Publication date
SE9700803D0 (sv) 1997-03-06
EP1003517A1 (de) 2000-05-31
WO1998039005A1 (en) 1998-09-11
SE9700803L (sv) 1998-09-07
DE69806248T2 (de) 2002-11-07
AU5893398A (en) 1998-09-22
DE69806248D1 (de) 2002-08-01
ATE219675T1 (de) 2002-07-15
EP1003517B1 (de) 2002-06-26
US6214837B1 (en) 2001-04-10

Similar Documents

Publication Publication Date Title
US6090822A (en) Treatment of cytokine growth factor caused disorders
KR100196674B1 (ko) 디페닐부틸-피페라진카르복사미드를 이용한 물질 남용 장애의 치료방법 및 그를 함유하는 약제학적 조성물
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE273958T1 (de) Heterocyclische verbindungen als h+-atpasen
FI3952880T3 (fi) 2-(2,6-dioksopiperidin-3-yyli)-4-((2-fluori-4-((3-morfolinoatsetidin-1-yyli)metyyli)bentsyyli)amino)isoindoliini-1,3-dioni käytettäväksi non-hodgkinin lymfooman hoidossa
US11077118B2 (en) Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake
JPH07505646A (ja) 神経伝達速度の減損を伴う障害，特に糖尿病性ニューロパシーに対するアンギオテンシンｉｉアンタゴニスト
CA2049368A1 (en) Treatment of cerebro-vascular disorders
ES2220975T3 (es) Tratamiento de trastornos producidos por factores de crecimiento de citoquina.
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
EA200601249A1 (ru) Пиперазины, пригодные для лечения боли
CN1060039C (zh) (r)-氨氯地平对平滑肌细胞移行的抑制
CZ285633B6 (cs) Použití indolových derivátů pro výrobu léčiv a farmaceutický prostředek
SE509618C2 (sv) Farmaceutisk komposition för behandling av s k restless legs
JPH11514654A (ja) 外傷による脳損傷の治療方法
AU704695B2 (en) Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders
JP2001507672A (ja) Ｃｉｓ―縮合シクロペンテノ―１，２，４―トリオキサン誘導体を含有する抗マラリア組成物
JPH02138173A (ja) 繊維筋痛症の治療
DE60219680D1 (de) Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit
RU2005126459A (ru) Производные диазепана, используемые в качестве ингибиторов lfa
SE9302334D0 (sv) New compounds
AU748754B2 (en) Treatment of hepatic cirrhosis
ATE269704T1 (de) Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens
RU2007124557A (ru) Применение отдельных соединений для защиты нейронов и олигодендроцитов при лечении рассеянного склероза
TH18632A (th) วิธียับยั้งโรคอัลไซเมอร์

Legal Events

Date Code Title Description
NUG Patent has lapsed